Active substanceLoperamideLoperamide
Similar drugsTo uncover
  • Vero-Loperamide
    pills inwards 
    VEROPHARM SA     Russia
  • Dyara
    pills inwards 
  • Diara®
    capsules inwards 
  • Imodium®
    pills inwards 
  • Imodium®
    capsules inwards 
  • Lopedium®
    capsules inwards 
    Sandoz d.     Slovenia
  • Lopedium®
    pills inwards 
    Sandoz d.     Slovenia
  • Loperamide
    capsules inwards 
    BIOKOM, CJSC     Russia
  • Loperamide
    pills inwards 
    PHARMACY 36.6, CJSC     Russia
  • Loperamide
    capsules inwards 
  • Loperamide
    pills inwards 
  • Loperamide
    pills inwards 
    BIOKOM, CJSC     Russia
  • Loperamide
    capsules inwards 
    NORTH STAR, CJSC     Russia
  • Loperamide
    pills inwards 
    OZONE, LLC     Russia
  • Loperamide
    pills inwards 
    LEKHIM-KHARKOV, CJSC     Ukraine
  • Loperamide Grindeks
    capsules inwards 
    GRINDEX, JSC     Latvia
  • Loperamide STADA
    capsules inwards 
    NIZHFARM, JSC     Russia
  • Loperamide-Akrihin
    capsules inwards 
    AKRIKHIN HFK, JSC     Russia
  • Sperilop
    capsules inwards 
  • Dosage form: & nbsppills
    Composition:

    1 tablet contains:

    active substance: Loperamide hydrochloride 2 mg.

    Excipients: lactose (milk sugar), starch potato, pregelatinized starch, croscarmellose sodium (impellose), magnesium stearate.

    Description:

    Tablets are white or white with a yellowish hue of color, round, flat-cylindrical with a bevel. Single blotches of light yellow color are allowed.

    Pharmacotherapeutic group:Antidiarrhoeic remedy
    ATX: & nbsp

    A.07.D.A   Drugs that reduce the peristalsis of the digestive tract

    A.07.D.A.03   Loperamide

    Pharmacodynamics:Loperamide, binding to opioid receptors of the intestinal wall (stimulation of cholinergic and adrenergic neurons through guanine nucleotides), reduces tone and motility of the smooth muscles of the intestine, slows the passage of the contents of the intestine, reduces the secretion of fluid and electrolytes with feces. Increases the tone of the anal sphincter, promotes retention of fecal masses and reduced urge to defecate. The action comes quickly and lasts 4-6 hours.
    Pharmacokinetics:

    Absorption - 40%. The connection with plasma proteins is 97%. The half-life is 9-14 hours. Does not penetrate blood-brain barrier. Getting into the systemic bloodstream, almost completely metabolized in the liver by conjugation.It is excreted mainly with bile, an insignificant part of the kidneys (in the form of conjugated metabolites).

    Indications:

    Symptomatic treatment of acute and chronic diarrhea of ​​various genesis (allergic, emotional, drug, radiation, with a change in diet and quality of food, in violation of metabolism and absorption, as an auxiliary for diarrhea of ​​infectious genesis).

    Regulation of stool in patients with ileostomy.

    Contraindications:

    Hypersensitivity to the drug, diverticulosis, intestinal obstruction, ulcerative colitis in the acute stage, diarrhea on the background of acute pseudomembranous enterocolitis, in the form of monotherapy - dysentery and other infections of the gastrointestinal tract; pregnancy (I trimester), lactation period, loperamide in tablets are not prescribed for children under 6 years.

    Carefully:

    Liver failure.

    Dosing and Administration:

    Inside. Adults with acute and chronic diarrhea initially assigned 2 tablets (4 mg), then 1 tablet (2 mg) after each act of defecation in the case of a loose stool. The maximum daily dose is 8 tablets (16 mg).

    Children over 6 years of age are prescribed 1 tablet (2 mg) after each act of defecation in the case of a loose stool. The maximum daily dose is 3 tablets (6 mg).

    After normalization of the stool or in the absence of stool for more than 12 hours, treatment with loperamide should be discontinued.

    Side effects:

    Discomfort in the abdomen, flatulence, gastralgia, dry mouth, allergic reactions (skin rash), intestinal colic, nausea, vomiting, constipation, headache, drowsiness or insomnia, dizziness. Rarely, urine retention. Very rarely - intestinal obstruction.

    Overdose:

    Symptoms: oppression of the central nervous system (stupor, impaired coordination, drowsiness, miosis, muscle hypertension, respiratory depression), intestinal obstruction.

    Treatment: antidote - naloxone; Considering that the duration of action of loperamide is greater than that of naloxone, it is possible to re-introduce the latter.

    Symptomatic treatment: Activated carbon, gastric lavage, artificial ventilation.

    Medical surveillance is necessary for at least 48 hours.
    Special instructions:

    If there is no effect after 2 days of loperamide use, it is necessary to clarify the diagnosis and exclude the infectious genesis of diarrhea.

    Effect on the ability to drive transp. cf. and fur:

    During the treatment period, care must be taken when driving vehicles and taking other potentially dangerous species activities that require increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:Tablets 2 mg.
    Packaging:

    10 tablets per contour cell pack. For 1 or 2 contour packs with instructions for use in a pack of cardboard.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 25 ° C. Keep out of the reach of children.

    Shelf life:

    3 years. Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-004065/09
    Date of registration:25.05.2009
    Expiration Date:Unlimited
    The owner of the registration certificate:BIOKOM, CJSC BIOKOM, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp02.04.2018
    Illustrated instructions
      Instructions
      Up